Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections.
about
Pathological and therapeutic significance of cellular invasion by Proteus mirabilis in an enterocystoplasty infection stone model.Etiological and Resistance Profile of Bacteria Involved in Urinary Tract Infections in Young Children.Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.Complete nucleotide sequence of Klebsiella pneumoniae multiresistance plasmid pJHCMW1.Natural antibiotic susceptibility of Proteus spp., with special reference to P. mirabilis and P. penneri strains.Plasmid-Mediated Antibiotic Resistance and Virulence in Gram-negatives: the Klebsiella pneumoniae Paradigm.Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, IndiaEmergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community.Urinary tract infection among intellectual disability individuals "etiology and antibiotic resistance patterns" in rehabilitation centers of Mazandaran province, Northern IranEpidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.Urinary tract infection among symptomatic outpatients visiting a tertiary hospital based in midwestern Nigeria.Comparison of antibiotic resistance patterns in collections of Escherichia coli and Proteus mirabilis uropathogenic strains.Emergency Department vancomycin use: dosing practices and associated outcomesGenome Sequences of Two Klebsiella pneumoniae Isolates from Different Geographical Regions, Argentina (Strain JHCK1) and the United States (Strain VA360)Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in AfricaWhole-Genome Comparative Analysis of Two Carbapenem-Resistant ST-258 Klebsiella pneumoniae Strains Isolated during a North-Eastern Ohio Outbreak: Differences within the High Heterogeneity Zones.Acute pyelonephritis: clinical characteristics and the role of the surgical treatment.Distribution and antimicrobial susceptibility pattern of bacterial pathogens causing urinary tract infection in urban community of meerut city, India.A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates.Treatment option for sepsis in children in the era of antibiotic resistance.Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates.Rapid and simple determination of ciprofloxacin resistance in clinical strains of Escherichia coliEfficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections.Antibiotic susceptibility of bacterial strains isolated from patients with various infections.Fosfomycin tromethamine in uncomplicated urinary tract infections: a clinical study.Risk factors for non-Escherichia coli community-acquired bacteriuria.Gender and age-dependent etiology of community-acquired urinary tract infections.Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
P2860
Q30870732-1E23F8BB-818F-4457-839B-10446BD71753Q33603991-03FBECA0-6AA2-4E6C-9FFD-9C633FEC14B1Q34073299-0B1490DF-EFE6-40E4-859E-4B5D0187FDC6Q34142178-C5C16EED-15C8-4C6D-8377-405E351814B5Q34188609-FF2C02ED-F281-44EA-B5A9-40760E5973A3Q35104348-F4EEB09F-4627-4C0F-9628-1AE255796E24Q35751357-DF02CF32-FBF8-4E54-AB68-F3B84042315EQ36139832-F9728958-D228-46FF-9BD4-BB3CFA89D486Q36478503-1176E0C1-54FD-49AE-B7D4-3FF7CC9E7EBAQ36598540-7190AC54-EC7D-4256-8C72-B51AD3CCB308Q36647553-FFA32B10-FA81-4024-A53E-8031BFD11204Q36676368-661F51EB-9AE9-4714-8688-54BD4EA32DBAQ36799447-0C331460-AA7A-45B5-8740-2417004AD332Q36812179-16C7800C-6A48-4A1C-B486-C02492295AD6Q37036409-2C53C534-CE65-40F2-900C-F50B22918F8AQ37090582-C20B4505-B427-4515-B3DB-3263475B1A6FQ37166597-DAC80CB3-F4CF-483D-A5D2-88859BDDAF6BQ37316260-CB787021-8D63-4F97-8F7D-F98964521835Q37899151-CF90139C-A4CA-4A94-88F8-68AD61D396D5Q38246118-926056E5-2A79-49EE-BFB7-248FCA0E2A4EQ41810485-0EEE262D-DDA9-4817-8E0E-E4C0B9AA09EAQ41835144-099A41F0-0F26-464D-A4AA-B04E683C484BQ43195355-A0222DC6-52BF-4FE6-B352-ECE468EBE1BBQ43902949-5E3FF449-514B-4FD1-858A-BDE88D082DE5Q46484493-76C1ABB7-E23D-44EE-9BC9-D534967F523BQ54325953-160D7FB5-BFDB-461F-A921-FDEB94E6A1FAQ54335778-D02EA4DE-D2A5-4174-85FE-BCFDC2207843Q54413391-7EE2A3C6-6845-42A9-9D20-8F83F32226FE
P2860
Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Antibiotic susceptibility of b ...... ired urinary tract infections.
@en
Antibiotic susceptibility of b ...... ired urinary tract infections.
@nl
type
label
Antibiotic susceptibility of b ...... ired urinary tract infections.
@en
Antibiotic susceptibility of b ...... ired urinary tract infections.
@nl
prefLabel
Antibiotic susceptibility of b ...... ired urinary tract infections.
@en
Antibiotic susceptibility of b ...... ired urinary tract infections.
@nl
P1476
Antibiotic susceptibility of b ...... uired urinary tract infections
@en
P2093
P304
P356
10.1016/S0924-8579(01)00389-2
P50
P577
2001-09-01T00:00:00Z